5U7Z
Human acid ceramidase (ASAH1, aCDase) self-activated
5U7Z の概要
エントリーDOI | 10.2210/pdb5u7z/pdb |
関連するPDBエントリー | 5U81 5U84 |
分子名称 | Acid ceramidase, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, SULFATE ION, ... (6 entities in total) |
機能のキーワード | ceramidase, ceramide, ntn-hydrolase, hydrolase |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 91673.11 |
構造登録者 | |
主引用文献 | Gebai, A.,Gorelik, A.,Li, Z.,Illes, K.,Nagar, B. Structural basis for the activation of acid ceramidase. Nat Commun, 9:1621-1621, 2018 Cited by PubMed Abstract: Acid ceramidase (aCDase, ASAH1) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes. Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer's, diabetes, and cancer. Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms. In the proenzyme, the catalytic center is buried and protected from solvent. Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site. Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage. A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D. Structural mapping of disease mutations reveals that most would destabilize the protein fold. These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics. PubMed: 29692406DOI: 10.1038/s41467-018-03844-2 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.5 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード